Phase 1 results of ZUMA-1: A multicenter study of KTE-C19 anti-CD19 CAR T cell therapy in refractory aggressive lymphoma [PDF]
Bartlett, Nancy L +2 more
core +2 more sources
The majority of adoptive cellular therapies are produced from peripheral mononuclear cells obtained via leukapheresis and further enriched for the cells of interest (e.g., T cells).
Anton Mukhamedshin +7 more
doaj +1 more source
Rapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells [PDF]
core +1 more source
Tandem extracorporeal blood purification therapies for sepsis and acute kidney injury in critically ill children: a state-of-the-art review. [PDF]
Shirode P +11 more
europepmc +1 more source
Burixafor, a CXCR4 inhibitor with a differentiated kinetics profile: results of a phase 2 study for rapid cell mobilization in multiple myeloma and lymphoma patients undergoing transplant. [PDF]
Sukhtankar DD +8 more
europepmc +1 more source
Current evidence and strategies for bridging therapy in CD19-directed chimeric antigen receptor T-cell therapy for relapsed/refractory large B-cell lymphomas. [PDF]
Lv J +5 more
europepmc +1 more source
Weisses Blut—Leukapheresis in acute leukemia [PDF]
Michael H A, Roehrl, W Sunny, Dzik
openaire +2 more sources
Gene Therapy for Sickle Cell Disease: Practice Recommendations from the American Society for Transplantation and Cellular Therapy and the International Society for Cell & Gene Therapy. [PDF]
Sharma A +19 more
europepmc +1 more source
Hyperleukocytosis in a Patient With Chronic Myeloid Leukemia and HIV: A Case Report. [PDF]
Chambi-Torres JB +4 more
europepmc +1 more source
Systematic Review of Immunosuppression After Chimeric Antigen Receptor T-Cell Therapy for Posttransplant Lymphoproliferative Disorder. [PDF]
Synnott D, Bowden A, Sexton DJ.
europepmc +1 more source

